Citation Impact
Citing Papers
Mutational Profile of Advanced Primary and Metastatic Radioactive Iodine-Refractory Thyroid Cancers Reveals Distinct Pathogenetic Roles for BRAF, PIK3CA , and AKT1
2009
Change of Serum Antithyroglobulin Antibody Levels Is Useful for Prediction of Clinical Recurrence in Thyroglobulin-Negative Patients with Differentiated Thyroid Carcinoma
2008
Prognostic Significance of Somatic RET Oncogene Mutations in Sporadic Medullary Thyroid Cancer: A 10-Year Follow-Up Study
2007
Cabozantinib in Progressive Medullary Thyroid Cancer
2013
The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota.
1994
Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.
1996
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Stress Hormone-Related Psychopathology: Pathophysiological and Treatment Implications
2001
Stress and Depression
2004 Standout
Psychiatric Disorders Associated with Cushing??s Syndrome
2001
Cancer treatment and survivorship statistics, 2022
2022 Standout
The role of acute and chronic stress in asthma attacks in children
2000
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma
2016
Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases
2004
Prognostic Impact of Serum Calcitonin and Carcinoembryonic Antigen Doubling-Times in Patients with Medullary Thyroid Carcinoma
2005
School based screening for hypothyroidism in Down's syndrome by dried blood spot TSH measurement
2000
Prognostic utility of BRAF mutation in papillary thyroid cancer
2009
Molecular pathology of thyroid cancer: diagnostic and clinical implications
2008
Calcitonin and carcinoembryonic antigen doubling times as prognostic factors in medullary thyroid carcinoma: a structured meta‐analysis
2009
Guidelines for radioiodine therapy of differentiated thyroid cancer
2008
Long-Term Impaired Quality of Life in Cushing’s Syndrome despite Initial Improvement after Surgical Remission
2006
MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects
2012
Thyroid cancer
2016 Standout
Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation
2002
Reliability of studies of iodine intake and recommendations for number of samples in groups and in individuals
2007
High Frequency of Bone/Bone Marrow Involvement in Advanced Medullary Thyroid Cancer
2005
Predictive Value of Serum Thyroglobulin After Surgery for Thyroid Carcinoma
2003
Plasma thyrotropin bioactivity in Down's syndrome children with subclinical hypothyroidism
2001
Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity
1998
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
Elevated level of serum carbohydrate antigen 19.9 as predictor of mortality in patients with advanced medullary thyroid cancer
2015
Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times
2008
Multivariate analysis of patients with medullary thyroid carcinoma: Prognostic significance and impact on treatment of clinical and pathologic variables
1996
Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
2003 Standout
Cognitive Function and Cerebral Assessment in Patients Who Have Cushing's Syndrome
2005
Psychiatric aspects of Cushing's syndrome
1996
Complementary Roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in Medullary Thyroid Cancer
2011
131 I Therapy for Elevated Thyroglobulin Levels
1997
Medullary Thyroid Cancer
1995
Psychosomatic Aspects of Cushing’s Disease
1998
Cushing's syndrome
2015 Standout
Phaeochromocytoma
2005 Standout
The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the guinea pig
2010 Standout
Clinical evaluation of tumor characteristics predisposing serum thyroglobulin to be undetectable in patients with differentiated thyroid cancer
1988
Long-term Course of Patients with Persistent Hypercalcitoninemia After Apparent Curative Primary Surgery for Medullary Thyroid Carcinoma
1990
Longitudinal study of thyroid function in Down's syndrome in the first two decades
2005
Radioisotope-guided surgery in patients with pheochromocytoma and recurrent medullary thyroid carcinoma
2001
Pancreatic cancer
2016 Standout
Serum Thyroglobulin Autoantibodies: Prevalence, Influence on Serum Thyroglobulin Measurement, and Prognostic Significance in Patients with Differentiated Thyroid Carcinoma1
1998
Long‐term prognosis of medullary thyroid carcinoma
2008
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
Clinical applications of 124I-PET/CT in patients with differentiated thyroid cancer
2011
Selenium and human health
2012 Standout
The Importance of Milk and other Animal-Source Foods for Children in Low-Income Countries
2011
BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment
2012
Changes in Clinical Presentation, Management and Outcome in 1348 Patients with Differentiated Thyroid Carcinoma: Experience in a Single Institute in Hong Kong, 1960–2000
2003
PSYCHONEUROENDOCRINOLOGY OF DEPRESSION
1998
Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease
2000
Risk of Malignancy in Nonpalpable Thyroid Nodules: Predictive Value of Ultrasound and Color-Doppler Features
2002 Standout
Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer
2007
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Selenium and the Course of Mild Graves' Orbitopathy
2011
Papillary and Follicular Thyroid Carcinoma
1998
Thyroid Imaging Reporting and Data System for US Features of Nodules: A Step in Establishing Better Stratification of Cancer Risk
2011 Standout
Genetics of congenital hypothyroidism
2005
The Timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center
2011
A Clinical Index for Rating Severity in Cushing’s Syndrome
2000
Mood and Anxiety Disorders as Early Manifestations of Medical Illness: A Systematic Review
2014
Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma
2004
Anti‐carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma
1997
Progression of postoperative residual medullary thyroid carcinoma as monitored by plasma calcitonin levels
1996
Graves' Ophthalmopathy
2010 Standout
The Interview for Recent Life Events
1997
Progress in molecular-based management of differentiated thyroid cancer
2013
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
The Diagnostic Value for Differentiated Thyroid Carcinoma Metastases of Thyroglobulin (Tg) Measurement in Washout Fluid from Fine-Needle Aspiration Biopsy of Neck Lymph Nodes Is Maintained in the Presence of Circulating Anti-Tg Antibodies
2006
Systematic Review of Depression, Anxiety, and Other Indicators of Psychological Distress Among U.S. and Canadian Medical Students
2006 Standout
Acute pretranslational regulation of type III iodothyronine deiodinase by growth hormone and dexamethasone in chicken embryos
1999
Treatment of medullary thyroid carcinoma: an update.
2001
Thyroglobulin antibody (TgAb) methods – Strengths, pitfalls and clinical utility for monitoring TgAb-positive patients with differentiated thyroid cancer
2013
Postoperative calcitonin study in medullary thyroid carcinoma.
2004
Natural History, Treatment, and Course of Papillary Thyroid Carcinoma*
1990 Standout
Management of the patient with progressive radioiodine non-responsive disease
1999
Ten Repeat Collections for Urinary Iodine from Spot Samples or 24-Hour Samples Are Needed to Reliably Estimate Individual Iodine Status in Women
2011
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
2015 Standout
Molecular Diagnosis of Residual and Recurrent Thyroid Cancer by Amplification of Thyroglobulin Messenger Ribonucleic Acid in Peripheral Blood1
1998
Affective Disorders and Endocrine Disease
1994
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Major Depressive Disorder
2008 Standout
Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans
2008
Phosphocitrate blocks calcification‐induced articular joint degeneration in a guinea pig model
2006
Extent of Surgery Affects Survival for Papillary Thyroid Cancer
2007 Standout
The Use and Misuse of Thyroid Hormone*
1993
Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy
2002
Cytotoxic Effects of Carboplatinum and Epirubicin in the Setting of an Elevated Serum Thyrotropin for Advanced Poorly Differentiated Thyroid Cancer
2002
Iodine-deficiency disorders
2008 Standout
Down's syndrome
2003 Standout
Management of Recurrent/Persistent Nodal Disease in Patients with Differentiated Thyroid Cancer: A Critical Review of the Risks and Benefits of Surgical Intervention Versus Active Surveillance
2014
Psychological aspects of endocrine disease
1998
SERUM THYROGLOBULIN MEASUREMENT
2001
Cushing's syndrome
2006 Standout
Differentiated thyroid carcinoma: Comparison between papillary and follicular carcinoma in a single institute
2002
Diagnostic Accuracy of 18F-FDG PET in Restaging Patients with Medullary Thyroid Carcinoma and Elevated Calcitonin Levels
2007
Health Supervision for Children With Down Syndrome
2011 Standout
Bone metastases from differentiated thyroid carcinoma
2008
Delayed Initial Radioactive Iodine Therapy Resulted in Poor Survival in Patients with Metastatic Differentiated Thyroid Carcinoma: A Retrospective Statistical Analysis of 198 Cases
2011
Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment
2004
Ghrelin: Structure and Function
2005 Standout
MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration
2012
The surgical treatment of medullary thyroid carcinoma
1999
A phase I study of cabozantinib (XL184) in patients with renal cell cancer
2014 StandoutNobel
Management of Patients with Scan Negative, Thyroglobulin Positive Differentiated Thyroid Carcinoma
1998
Serum thyroglobulin determination in the follow-up of patients with differentiated thyroid carcinoma
1998
131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma
1996
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
2004
Down's syndrome and anaesthesia
1995
Can Meditation Slow Rate of Cellular Aging? Cognitive Stress, Mindfulness, and Telomeres
2009 StandoutNobel
Functional characterization of the MTC-associated germline RET-K666E mutation: evidence of oncogenic potential enhanced by the G691S polymorphism
2011
Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma
1994
The Influence of Gender, Age, and RET Polymorphisms on C-Cell Hyperplasia and Medullary Thyroid Carcinoma
2008
Lack of Elevated Serum Carcinoembryonic Antigen and Calcitonin in Medullary Thyroid Carcinoma
2004
Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum
2011 Standout
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Prevalence and Clinical Spectrum of Nonsecretory Medullary Thyroid Carcinoma in a Series of 839 Patients with Sporadic Medullary Thyroid Carcinoma
2012
Evidence of a Low Prevalence of RAS Mutations in a Large Medullary Thyroid Cancer Series
2012
Outcomes and Prognostic Factors of 251 Patients with Minimally Invasive Follicular Thyroid Carcinoma
2012
Selenium in Human Health and Disease
2010
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
2009
American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer
2012
Low Prevalence of the Somatic M918T RET Mutation in Micro-Medullary Thyroid Cancer
2012
Clinical Trials for Progressive Differentiated Thyroid Cancer: Patient Selection, Study Design, and Recent Advances
2009
A Phase II Study of Gefitinib in Patients with Advanced Thyroid Cancer
2007
Relationship Between Tumor Burden and Serum Thyroglobulin Level in Patients with Papillary and Follicular Thyroid Carcinoma
2002
Prognostic Factors and Therapeutic Strategy for Anaplastic Carcinoma of the Thyroid
2001
Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid: A retrospective study of 109 consecutive patients
1996
Antithyroglobulin antibodies in patients with differentiated thyroid carcinoma: methods of detection, interference with serum thyroglobulin measurement and clinical significance
2004
Down Syndrome
2020 Standout
Selenium in the Environment, Metabolism and Involvement in Body Functions
2013 Standout
Modified neck dissection for patients with nonadvanced, differentiated carcinoma of the thyroid
1988 StandoutNobel
Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
1996
Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy
2006
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
2002 Standout
Medullary Thyroid Carcinoma
1998
Embolization for Vertebral Metastases of Follicular Thyroid Carcinoma
2000 Standout
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma
1985
The role of ultrasound findings in the management of thyroid nodules with atypia or follicular lesions of undetermined significance
2013
Thyroglobulin determination, neck ultrasonography and iodine-131 whole-body scintigraphy in differentiated thyroid carcinoma.
1996
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy
2005
Advances in the Diagnosis and Treatment of Medullary Thyroid Carcinoma
1987
Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism
1995 Standout
The Natural History of Benign Thyroid Nodules
2015
Physiological and Molecular Basis of Thyroid Hormone Action
2001 Standout
Effects of Thyroid Hormones on Bone and Mineral Metabolism
1990
Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients
2006
Quality of Life and Other Outcomes in Children Treated for Cushing Syndrome
2013
Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis.
2007
Risk factors and long-term outcome in pituitary-dependent Cushing's disease.
1996
The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
2005
Current status and performance goals for serum thyroglobulin assays
1996
Cancer treatment and survivorship statistics, 2019
2019 Standout
The Role of Radiation Therapy in the Treatment of Medullary Thyroid Cancer
2010
Brain Corticosteroid Receptor Balance in Health and Disease*
1998 Standout
Medullary Thyroid Cancer: An Immunohistochemical and Humoral Study Using Six Separate Antigens
1991
Characterization of Thyroid Abnormalities in a Large Cohort of Children with Down Syndrome
2017
Meat consumption, health, and the environment
2018 StandoutScience
Combination of Radioiodine (131I) and Probe-Guided Surgery for Persistent or Recurrent Thyroid Carcinoma
1998
Impact of Initial Surgical Treatment on Survival of Patients with Differentiated Thyroid Cancer: Experience of an Endocrine Surgery Center in an Iodine‐deficient Region
2000
BRAF Mutation in Papillary Thyroid Cancer: Pathogenic Role, Molecular Bases, and Clinical Implications
2007
Anti-carcinoembryonic antigen antibodies versus somatostatin analogs in the detection of metastatic medullary thyroid carcinoma
1997
Differentiated Thyroid Cancer: “Complete” Rational Approach
2000
TheBRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study
2012
The Longitudinal Course of Psychopathology in Cushing’s Syndrome after Correction of Hypercortisolism
1997
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
BRAFV600E mutation and Its Association with Clinicopathological Features of Papillary Thyroid Cancer: A Meta-Analysis
2012
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
2005
Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline
2012 Standout
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
2008 Standout
Clinical spectrum of MEN2A in a large family caused by the infrequent RET mutation Cys609Phe
2012
Thyroid carcinoma
2003 Standout
Evidence‐based Approach to the Management of Sporadic Medullary Thyroid Carcinoma
2007
BRAFV600E Mutation Analysis in Papillary Thyroid Carcinoma: Is it Useful for all Patients?
2013
Works of M. E. Girelli being referenced
Iodine status in schoolchildren living in northeast italy:the importance of iodized-salt use and milk consumption
2013
Life events in the pathogenesis of Graves' disease. A controlled study
1993
A multimodality therapeutic approach in anaplastic thyroid carcinoma: Study on 39 patients
2000
Natural course of subclinical hypothyroidism in Down’s syndrome: Prospective study results and therapeutic considerations
1995
Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification
2011
Milk represents an important source of iodine in schoolchildren of the Veneto region, Italy
2004
Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis
2009
RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series
2008
Characterization of the largest kindred with MEN2A due to a Cys609Ser RET mutation
2009
A Novel Mutation in the Thyrotropin (TSH) Receptor Gene Causing Loss of TSH Binding But Constitutive Receptor Activation in a Family with Resistance to TSH1
2000
Acute and chronic effects of high glucocorticoid levels on hypothalamic-pituitary-thyroid axis in man
1992
BRAF in primary and recurrent papillary thyroid cancers: the relationship with 131I and 2-[18F]fluoro-2-deoxy-d-glucose uptake ability
2010
Restricted intraindividual urinary iodine concentration variability in nonfasting subjects
2005
Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer
1991
Medullary Thyroid Carcinoma: Clinical Features and Long-Term Follow-up of Seventy-Eight Patients Treated Between 1969 and 1986
1998
Course of Depression in Cushing’s Syndrome: Response to Treatment and Comparison with Graves’ Disease
1993
Usefulness of the combined antithyroglobulin antibodies and thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer
1990
Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake
2007
MicroRNA Profiles in Familial and Sporadic Medullary Thyroid Carcinoma: Preliminary Relationships with RET Status and Outcome
2012
Parathyroid Hormone and Calcitonin in Thyrotoxicosis
1984
Different features of pulmonary metastases in differentiated thyroid cancer: natural history and multivariate statistical analysis of prognostic variables.
1993
BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience
2010
TSH Levels and TSH Response to TRH as a Guide to the Replacement Treatment of Patients with Thyroid Carcinoma
1976
Twenty-four hour variations of triiodothyronine (T3) levels in patients who had thyroid ablation for thyroid cancer, receiving T3 as suppressive treatment
1980
The Extent of Surgery for Thyroid Medullary Cancer
1994
Thyroid function in patients with Down syndrome: Preliminary results from non-institutionalized patients in the Veneto region
2005
Nonparallel patterns of calcitonin and carcinoembryonic antigen levels in the follow-up of medullary thyroid carcinoma
1984
Pregnancy After High Therapeutic Doses of Iodine-131 in Differentiated Thyroid Cancer
1993
Comparison of the diagnostic accuracy of combined elastosonography and BRAF analysis vs cytology and ultrasonography for thyroid nodule suspected of malignancy
2012
Effects of dextro-thyroxine, a preparation almost free of levo-thyroxine, on thyroid function, serum lipids and apolipoprotein A-I in “Double pre-beta lipoproteinemia”
1984
Prognostic Value of Early Postoperative Calcitonin Level in Medullary Thyroid Carcinoma
1994
Pulmonary metastases from differentiated thyroid carcinoma detected only by radionuclide imaging
1981
Critical evaluation of serum thyroglobulin (Tg) levels during thyroid hormone suppression therapy versus Tg levels after hormone withdrawal and total body scan: Results in 291 patients with thyroid cancer
1986
Different rates of thyrotropin suppression after total body scan in patients with thyroid cancer: effect of regular doses of thyroxine and triiodothyronine
1983